Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Univalent antibodies kill tumour cells in vitro and in vivo

Abstract

Antibody molecules are bivalent, or less often multivalent, with each antibody site within a single molecule having the same specificity. Bivalency must enhance the tenacity of antibody attachment to cell surfaces, as dissociation will require simultaneous release at both sites. However, the bivalency of the antibody sometimes induces a target cell to undergo antigenic modulation1–3, thereby offering the cell a means of evading complement and the various effector cells recruited by the antibody. We have investigated the attack by univalent antibodies, which, despite removal of one antibody site, retain their Fc zones and hence their ability to recruit the killing agents, on neoplastic B lymphocytes of the guinea pig L2C line. Rabbit antibodies raised against surface immunoglobulin of these cells were partially digested with papain to yield the univalent Fab/c derivatives4,5. We report here that these derivatives showed enhanced cell killing both in vitro and in vivo, and that this enhancement appeared to derive from avoiding antigenic modulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Boyse, E. A. & Old, L. J. A. Rev. Genet. 3, 269–290 (1969).

    Article  Google Scholar 

  2. Stackpole, C. W., Jacobson, J. B. & Lardis, M. P. J. exp. Med. 140, 939–953 (1974).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gordon, J. & Stevenson, G. T. Immunology 42, 13–17 (1981).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Goodman, J. W. Biochemistry 4, 2350–2357 (1965).

    Article  CAS  Google Scholar 

  5. Michaelsen, T. E. & Natvig, J. B. Scand. J. Immun. 1255–1268 (1972).

  6. Stevenson, G. T., Eady, R. P., Hough, D. W., Jurd, R. D. & Stevenson, F. K. Immunology 28, 807–820 (1975).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Hough, D. W., Chapple, J. C., Stevenson, F. K. & Stevenson, G. T. Immunology 34, 889–899 (1978).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Stevenson, F. K., Elliott, E. V. & Stevenson, G. T. Immunology 32, 549–557 (1977).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Stevenson, G. T., Elliott, E. V. & Stevenson, F. K. Fedn Proc. 36, 2268–2271 (1977).

    CAS  Google Scholar 

  10. Press, E. M. Biochem. J. 149, 285–288 (1975).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Isenman, D. E., Dorrington, K. J. & Painter, R. H. J. Immun. 114, 1726–1729 (1975).

    CAS  PubMed  Google Scholar 

  12. Lamm, M. E., Boyse, E. A., Old, L. J., Lisowska-Bernstein, B. & Stockert, E. J. Immun. 101, 99–103 (1968).

    CAS  PubMed  Google Scholar 

  13. Taylor, R. B., Duffus, P. H., Raff, M. C. & de Petria, S. Nature new Biol. 233, 225–227 (1971).

    Article  CAS  PubMed  Google Scholar 

  14. Metzger, H. Contemp. Topics molec. Immun. 8, 119–152 (1978).

    Article  Google Scholar 

  15. Sissons, J. G. P. et al. J. exp. Med. 150, 445–454 (1979).

    Article  Google Scholar 

  16. Hamblin, T. J., Abdul-Ahad, A. K., Gordon, J., Stevenson, F. K. & Stevenson, G. T. Br. J. Cancer 42, 495–502 (1980).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Prahl, J. W., Mandy, W. J. & Todd, C. W. Biochemistry 8, 4935–4940 (1970).

    Article  Google Scholar 

  18. Fanger, M. W. & Smyth, D. G. Biochem. J. 127, 767–774 (1972).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Gordon, J., Robinson, D. S. F. & Stevenson, G. T. Immunology 42, 7–12 (1981).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Peto, R. Br. J. Cancer 29, 101–105 (1974).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glennie, M., Stevenson, G. Univalent antibodies kill tumour cells in vitro and in vivo. Nature 295, 712–714 (1982). https://doi.org/10.1038/295712a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/295712a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing